Revolution Medicines RVMD
NASDAQ RVMD
$192.28 +14.63 (+8.24%)
At close: Nov 6, 2026 · 4:00 PM EST

Revolution Medicines (RVMD) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Revolution Medicines (RVMD) posted Weighted Average Shares Outstanding (Diluted) of 210.89 million for Q2 2026, up 11.8% from 188.58 million a year earlier and up 6.5% from the prior quarter.

Analysis

Revolution Medicines (RVMD) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Revolution Medicines' Weighted Average Shares Outstanding (Diluted) came in at 190.13 million, up 13.3% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 28.2% (FY2020 to FY2025).
  • In prior years, Revolution Medicines' Weighted Average Shares Outstanding (Diluted) was 167.74 million in FY2024 (+48.2%), 113.15 million in FY2023 (+40.3%), 80.63 million in FY2022 (+10.7%) and 72.81 million in FY2021 (+32.7%).
  • The Q2 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2020.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last 19 quarters, with growth averaging 21.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding (Diluted) ranged from 1.2% (Q2 2022) to 73.7% (Q1 2024).
  • According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 198.1 million (Q1 2026), 190.13 million (Q4 2025) and 189.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 2.45 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 1.77 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - 1.96 Bn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 1.56 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 5.75 Bn
10 Revolution Medicines 41.45 Bn 29.93 Bn 197.23 Mn 214.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 214.95 Mn
Jun 30, 2026 210.89 Mn
Mar 31, 2026 198.10 Mn
Dec 31, 2025 190.13 Mn
Sep 30, 2025 189.23 Mn
Jun 30, 2025 188.58 Mn
Mar 31, 2025 188.15 Mn
Dec 31, 2024 167.74 Mn
Sep 30, 2024 166.84 Mn
Jun 30, 2024 165.14 Mn
Mar 31, 2024 164.73 Mn
Dec 31, 2023 113.15 Mn
Sep 30, 2023 109.23 Mn
Jun 30, 2023 106.88 Mn
Mar 31, 2023 94.83 Mn
Dec 31, 2022 80.63 Mn
Sep 30, 2022 84.69 Mn
Jun 30, 2022 74.28 Mn
Mar 31, 2022 74.16 Mn
Dec 31, 2021 72.81 Mn
API Access

Revolution Medicines Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RVMD&period=max&api_key=YOUR_API_KEY